Abstract
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have